News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Safety and efficacy of PD-1 inhibitor combined with transarterial chemoembolization for intermediate-stage HCC
Source: Depositphotos
Jan 22, 2025, 14:55

Safety and efficacy of PD-1 inhibitor combined with transarterial chemoembolization for intermediate-stage HCC

Journal for ImmunoTherapy of Cancer shared a post on X:

“New JITC article: Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria.”

Safety and efficacy of PD-1 inhibitor combined with transarterial chemoembolization for intermediate-stage HCC

Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria

Authors: Lixing Li, Xin Xu, Wentao Wang, Peiran Huang, Lei Yu, Zhenggang Ren, Jia Fan, Jian Zhou, Lan Zhang, Zheng Wang

Safety and efficacy of PD-1 inhibitor combined with transarterial chemoembolization for intermediate-stage HCC

 

cancer Jia Fan Jian Zhou Journal for ImmunoTherapy of Cancer Lan Zhang Lei Yu Lixing Li OncoDaily Oncology Peiran Huang Wentao Wang Xin Xu Zheng Wang Zhenggang Ren
Special Coverage
Blog
May 21, 2025, 06:28
Irina Ghazaryan Explores Uzbekistan's Healthcare Market at Plug and Play Expo
Blog
May 21, 2025, 06:19
George Kapetanakis: Honored to Participate at Cancer Planners Forum!
Blog
May 21, 2025, 06:06
Mandy Davis Aitken: We are Getting Ready for ASCO25, Are you?
Blog
May 21, 2025, 06:00
Charles Mullighan Has Been Elected as a Fellow of The Royal Society of London - St. Jude Children's Research Hospital
Blog
May 21, 2025, 05:49
Natalia Baran: GD3 Synthase Drives Resistance to p53-Induced Apoptosis in Breast Cancer by Modulating Mitochondrial Function
Blog
May 21, 2025, 05:38
King Hussein Cancer Foundation and Center Signs Cooperation Agreement with United Mission for Relief and Development
Blog
May 21, 2025, 04:12
Matthias Guckenberger: Spring meeting of the EORTC Lung Cancer Group
Blog
May 21, 2025, 03:33
Armenia’s Commitment to Cancer Care is very impressive - The Max Foundation
Blog
May 21, 2025, 01:40
Teresa Amaral: 5th edition of YO Congress
Blog
May 20, 2025, 17:22
The Lancet Group's Editorial Team Will Be on the Ground at ASCO 2025
Blog
May 20, 2025, 17:11
Pam Traxel: One in Ten Cancer Survivors Rely on Medicaid - Cuts Have Consequences
Blog
May 20, 2025, 16:58
Elvina Majiwa and Murallitharan Munisamy Have Won The World No Tobacco Day Award - UICC